D KEITH GROSSMAN
CIK 1218702 · Executive Chairman · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.04M
Companies
9
Total Filings
115
Lifetime Open-Market Net
-$10.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | Director | 37,430 | $4.49 | $168.1K | -$1.10M | 19 | 2026-06-05 |
| MMED | Director | 13,889 | $15.16 | $210.6K | $0 | 1 | 2026-03-11 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $939.0K | 43 | 2025-04-03 |
| ViewRay, Inc. (VRAY) Delisted | Director | 100,855 | $0.03 | $2.5K | $0 | 6 | 2021-01-05 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | $0 | 6 | 2017-04-28 |
| THORATEC CORP (THOR) Delisted | President & Chief Exec Officer | 602,050 | — | — | -$2.32M | 20 | 2015-10-08 |
| CONCEPTUS INC (CPTS) Delisted | President & CEO | 204,882 | — | — | $0 | 3 | 2013-02-11 |
| ISRG | Director | 4,050 | $411.06 | $1.66M | -$8.12M | 13 | 2010-04-23 |
| KYPHON INC (KYPH) Delisted | Director | 64 | — | — | $0 | 2 | 2007-05-09 |
Recent Filings · Page 7 of 12
115 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-20 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,994 | -$401.0K | EDGAR |
| 2020-01-06 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | +12,707 | $0 | EDGAR |
| 2019-12-20 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,507 | -$502.5K | EDGAR |
| 2019-09-20 | NEVRO CORP (NVRO) Delisted | Tax (F) | −3,912 | -$349.4K | EDGAR |
| 2019-06-21 | NEVRO CORP (NVRO) Delisted | Tax (F) | −3,201 | -$206.1K | EDGAR |
| 2019-03-21 | NEVRO CORP (NVRO) Delisted | Grant (A) | +111,111 | $0 | EDGAR |
| 2019-01-03 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | +27,596 | $55.0K | EDGAR |
| 2018-12-26 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-03 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-28 | Zeltiq Aesthetics Inc (ZLTQ) Delisted | Other (J) | −14,137 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.